Analyst Ratings for Myriad Genetics (MYGN)

MYGN Rating Summary

MYGN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MYGN
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $32.10 (-4.3%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
11/10/2014 Morgan Stanley New Coverage Underweight
(N/A)
25.00
(N/A)
34.89 33.53 -3.9% Details
4/4/2014 Mizuho Securities Upgrade Buy
(Neutral)
50.00
(40.00)
40.25 33.53 -16.7% Details
Like MYGN Ratings? Also take a look at TSRO, ABBV, AZN

MYGN Ratings News